Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New mobilization and exercise techniques show promise for easing period pain

NCT ID NCT07314021

Symptom relief Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study tested two non-drug approaches—FEMOB mobilization and MOPEXE exercises—for reducing pain in women with primary dysmenorrhea (period pain). 72 women aged 18-30 were split into four groups: one received FEMOB, one MOPEXE, one electrotherapy only, and one no treatment. The goal was to see which method best eased pain and improved attitudes toward menstruation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
FEMOB mobilization technique (including TENS, hot pack, joint mobilizations, myofascial release, and kinesio taping) and MOPEXE exercise model (motor imagery-focused exercises with electrotherapy)
What this could lead to
If successful, these techniques could offer drug-free options for managing period pain.
What could go wrong
This is a small, completed study with no blinding, so results may be less reliable. The techniques are not widely tested, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Dec 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18-30 years * Clinically confirmed primary dysmenorrhea * Regular menstrual cycles during the previous six months * Menstrual pain intensity of ≥4 cm on the Visual Analog Scale (VAS) * Voluntary agreement to participate in the study Exclusion Criteria: * Secondary dysmenorrhea or gynecological pathology such as endometriosis, uterine fibroids, or pelvic inflammatory disease * Pregnancy * Pelvic physiotherapy within the previous six months * Neurological, rheumatological, or serious systemic disease * Communication difficulties preventing participation or questionnaire completion * Regular use of oral contraceptives

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary dysmenorrhea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity primary dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Primary dysmenorrhea

Contacts and locations

Locations

  • Medipol University

    Istanbul, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.